p53 independent radio-sensitization of human lymphoblastoid cell lines by Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin

Oncology Reports

Volumn 23, Issue 1, 2010, Pages 199-203

  Fujii, Yoshihiro ^a,b,c   Kato, Takamitsu ^c   Kubota, Nobuo ^a   Fujimori, Akira ^c   Niwa, Ohtsura ^c   Okayasu, Ryuichi ^c  

^a IBARAKI PREFECTURAL UNIVERSITY OF HEALTH SCIENCES   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

17 allylamino 17 demethoxygeldanamycin; Heat shock protein 90; p53 status; Radiation

Indexed keywords

HEAT SHOCK PROTEIN 90; PROTEIN P53; TANESPIMYCIN;

APOPTOSIS; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFECT; GROWTH INHIBITION; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; PRIORITY JOURNAL; RADIOSENSITIZATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BENZOQUINONES; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; HSP90 HEAT-SHOCK PROTEINS; HUMANS; LACTAMS, MACROCYCLIC; LYMPHOCYTES; MUTATION; RADIATION TOLERANCE; SIGNAL TRANSDUCTION; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 76049120956     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or-00000623     Document Type: Article

References (37)

1. Freeman BC and Morimoto RI: The human cytosolic molecular chaperones hsp90, hsp70 (hsc70) and hdj-1 have distinct roles in recognition of a non-native protein and protein refolding. EMBO J 15: 2969-2979, 1996.
2. Kamal A, Thao L, Sensintaffar J, et al: A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors. Nature 425: 407-410, 2003.
3. Garcia-Morales P, Carrasco-Garcia E, Ruiz-Rico P, et al: Inhibition of Hsp90 function by ansamycins causes down-regulation of cdc2 and cdc25c and G(2)/M arrest in glioblastoma cell lines. Oncogene 26: 7185-7193, 2007.
4. Gray PJ Jr, Stevenson MA and Calderwood SK: Targeting Cdc37 inhibits multiple signaling pathways and induces growth arrest in prostate cancer cells. Cancer Res 67: 11942-11950, 2007.
5. Xu W, Mimnaugh E, Rosser MF, et al: Sensitivity of mature Erbb2 to geldanamycin is conferred by its kinase domain and is mediated by the chaperone protein Hsp90. J Biol Chem 276: 3702-3708, 2001.
6. Pratt WB and Toft DO: Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr Rev 18: 306-360, 1997.
7. Blagosklonny MV, Toretsky J and Neckers L: Geldanamycin selectively destabilizes and conformationally alters mutated p53. Oncogene 11: 933-939, 1995.
8. Tsutsumi S and Neckers L: Extracellular heat shock protein 90: a role for a molecular chaperone in cell motility and cancer metastasis. Cancer Sci 98: 1536-1539, 2007.
9. Powers MV and Workman P: Targeting of multiple signalling pathways by heat shock protein 90 molecular chaperone inhibitors. Endocr Relat Cancer 13 (Suppl 1): S125-S135, 2006.
10. Bao XQ and Liu GT: Heat shock proteins: new target in cytoprotective and tumor therapy. Yao Xue Xue Bao 43: 234-240, 2008.
11. Mimnaugh EG, Chavany C and Neckers L: Polyubiquitination and proteasomal degradation of the p185c-erbB-2 receptor protein-tyrosine kinase induced by geldanamycin. J Biol Chem 271: 22796-22801, 1996.
12. Stancato LF, Silverstein AM, Owens-Grillo JK, et al: The hsp90-binding antibiotic geldanamycin decreases Raf levels and epidermal growth factor signaling without disrupting formation of signaling complexes or reducing the specific enzymatic activity of Raf kinase. J Biol Chem 272: 4013-4020, 1997.
13. Machida H, Nakajima S, Shikano N, et al: Heat shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin potentiates the radiation response of tumor cells grown as monolayer cultures and spheroids by inducing apoptosis. Cancer Sci 96: 911-917, 2005.
14. Bisht KS, Bradbury CM, Mattson D, et al: Geldanamycin and 17-allylamino-17-demethoxygeldanamycin potentiate the in vitro and in vivo radiation response of cervical tumor cells via the heat shock protein 90-mediated intracellular signaling and cytotoxicity. Cancer Res 63: 8984-8995, 2003.
15. Noguchi M, Yu D, Hirayama R, et al: Inhibition of homologous recombination repair in irradiated tumor cells pretreated with Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin. Biochem Biophys Res Commun 351: 658-663, 2006.
16. Goetz MP, Toft D, Reid J, et al: Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer. J Clin Oncol 23: 1078-1087, 2005.
17. Fan S, el-Deiry WS, Bae I, et al: p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Cancer Res 54: 5824-5830, 1994.
18. Lane DP: Cancer. p53, guardian of the genome. Nature 358: 15-16, 1992.
19. Shintani S, Zhang T, Aslam A, et al: P53-dependent radio-sensitizing effects of Hsp90 inhibitor 17-allylamino-17- demethoxygeldanamycin on human oral squamous cell carcinoma cell lines. Int J Oncol 29: 1111-1117, 2006.
20. Xia F, Wang X, Wang YH, et al: Altered p53 status correlates with differences in sensitivity to radiation-induced mutation and apoptosis in two closely related human lymphoblast lines. Cancer Res 55: 12-15, 1995.
21. Amundson SA, Xia F, Wolfson K, et al: Different cytotoxic and mutagenic responses induced by X-rays in two human lymphoblastoid cell lines derived from a single donor. Mutat Res 286: 233-241, 1993.
22. Xia F, Amundson SA, Nickoloff JA, et al: Different capacities for recombination in closely related human lymphoblastoid cell lines with different mutational responses to X-irradiation. Mol Cell Biol 14: 5850-5857, 1994.
23. Furth EE, Thilly WG, Penman BW, et al: Quantitative assay for mutation in diploid human lymphoblasts using microtiter plates. Anal Biochem 110: 1-8, 1981.
24. Scott D, Spreadborough AR, Jones LA, et al: Chromosomal radiosensitivity in G2-phase lymphocytes as an indicator of cancer predisposition. Radiat Res 145: 3-16, 1996.
25. Roberts SA, Spreadborough AR, Bulman B, et al: Heritability of cellular radiosensitivity: a marker of low-penetrance predisposition genes in breast cancer? Am J Hum Genet 65: 784-794, 1999.
26. Scott D, Barber JB, Spreadborough AR, et al: Increased chromosomal radiosensitivity in breast cancer patients: a comparison of two assays. Int J Radiat Biol 75: 1-10, 1999.
27. Bull EE, Dote H, Brady KJ, et al: Enhanced tumor cell radio-sensitivity and abrogation of G2 and S phase arrest by the Hsp90 inhibitor 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin. Clin Cancer Res 10: 8077-8084, 2004.
28. Kerr JF, Wyllie AH and Currie AR: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239-257, 1972.
29. Jha AN, Hande PM, Mullenders LH, et al: Mimosine is a potent clastogen in primary and transformed hamster fibroblasts but not in primary or transformed human lymphocytes. Mutagenesis 10: 385-391, 1995.
30. Schafer J, Bachtler J, Engling A, et al: Suppression of apoptosis and clonogenic survival in irradiated human lymphoblasts with different TP53 status. Radiat Res 158: 699-706, 2002.
31. Yu Y, Li CY and Little JB: Abrogation of p53 function by HPV16 E6 gene delays apoptosis and enhances mutagenesis but does not alter radiosensitivity in TK6 human lymphoblast cells. Oncogene 14: 1661-1667, 1997.
32. Georgakis GV, Li Y and Younes A: The heat shock protein 90 inhibitor 17-AAG induces cell cycle arrest and apoptosis in mantle cell lymphoma cell lines by depleting cyclin D1, Akt, Bid and activating caspase 9. Br J Haematol 135: 68-71, 2006.
33. Zhao C and Wang E: Heat shock protein 90 suppresses tumor necrosis factor alpha induced apoptosis by preventing the cleavage of Bid in NIH3T3 fibroblasts. Cell Signal 16: 313-321, 2004.
34. Kastan MB, Onyekwere O, Sidransky D, et al: Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51: 6304-6311, 1991.
35. Taylor WR and Stark GR: Regulation of the G2/M transition by p53. Oncogene 20: 1803-1815, 2001.
36. Lobrich M and Jeggo PA: The impact of a negligent G2/M checkpoint on genomic instability and cancer induction. Nat Rev Cancer 7: 861-869, 2007.
37. Krempler A, Deckbar D, Jeggo PA, et al: An imperfect G2M checkpoint contributes to chromosome instability following irradiation of S and G2 phase cells. Cell Cycle 6: 1682-1686, 2007.